Ameliorating effect of luteolin on memory impairment in an Alzheimer's disease model

Molecular Medicine Reports

Volumn 13, Issue 5, 2016, Pages 4215-4220

  Wang, Huimin ^a   Wang, Huiling ^b   Cheng, Huixin ^a   Che, Zhenyong ^a  

^a XINXIANG CENTRAL HOSPITAL   (China)

^b Department of Radiotherapy   (China)

Author keywords

Alzheimer's disease; Luteolin; Morris water maze test

Indexed keywords

LUTEOLIN; STREPTOZOCIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MONOTHERAPY; MORRIS WATER MAZE TEST; NONHUMAN; PATHOGENESIS; RAT; SPATIAL LEARNING; TISSUE PREPARATION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPAL CA1 REGION; MAZE TEST; MEMORY; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ALZHEIMER DISEASE; ANIMALS; CA1 REGION, HIPPOCAMPAL; DISEASE MODELS, ANIMAL; LUTEOLIN; MALE; MAZE LEARNING; MEMORY; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 84964766316     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.5052     Document Type: Article

References (47)

1. Zhu Z, Yan J, Jiang W, Yao XG, Chen J, Chen L, Li C, Hu L, Jiang H and Shen X: Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance. J Neurosci 33:13138-13149, 2013.
2. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA and Katzman R: Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580, 1991.
3. Choi SM, Kim BC, Cho YH, Choi KH, Chang J, Park MS, Kim MK, Cho KH and Kim JK: Effects of flavonoid compounds on β-amyloid-peptide-induced neuronal death in cultured mouse cortical neurons. Chonnam Med J 50:45-51, 2014.
4. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA and Freedman ML: Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 150:40-44, 1998.
5. Zheng L, Kâgedal K, Dehvari N, Benedikz E, Cowburn R, Marcusson J and Terman A: Oxidative stress induces macroautophagy of amyloid beta-protein and ensuing apoptosis. Free Radic Biol Med 46:422-429, 2009.
6. Behl C and Holsboer F: Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection. Fortschr Neurol Psychiatr 66:113-121, 1998 (In German).
7. Peng QL, Buz'Zard AR and Lau BH: Pycnogenol protects neurons from amyloid-beta peptide-induced apoptosis. Brain Res Mol Brain Res 104:55-65, 2002.
8. Andersen JK: Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10 Suppl: S18-S25, 2004.
9. Butterfield DA, Perluigi M and Sultana R: Oxidative stress in Alzheimer's disease brain: New insights from redox proteomics. Eur J Pharmacol 545:39-50, 2006.
10. Aliev G, Obrenovich ME, Reddy VP, Shenk JC, Moreira PI, Nunomura A, Zhu X, Smith MA and Perry G: Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Rev Med Chem 8:1395-1406, 2008.
11. Lin YH, Liu AH, Wu HL, Westenbroek C, Song QL, Yu HM, Ter Horst GJ and Li XJ: Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents Abeta (25-35)-induced reduction in BPRP in PC12 cells. Biochem Biophys Res Commun 348:593-599, 2006.
12. Merken HM and Beecher GR: Measurement of food flavonoids by high-performance liquid chromatography: A review. J Agric Food Chem 48:577-599, 2000.
13. Rice-Evans CA, Miller NJ and Paganga G: Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933-956, 1996.
14. Zeng LH, Zhang HD, Xu CJ, Bian YJ, Xu XJ, Xie QM and Zhang RH: Neuroprotective effects of flavonoids extracted from licorice on kainate-induced seizure in mice through their antioxidant properties. J Zhejiang Univ Sci B 14:1004-1012, 2013.
15. Dugas AJ Jr, Castañeda-Acosta J, Bonin GC, Price KL, Fischer NH and Winston GW: Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: Structure-activity relationships. J Nat Prod 63:327-331, 2000.
16. Cho JG, Song NY, Nam TG, Shrestha S, Park HJ, Lyu HN, Kim DO, Lee G, Woo YM, Jeong TS, et al: Flavonoids from the grains of C1/R-S transgenic rice, the transgenic Oryza sativa spp. japonica, and their radical scavenging activities. J Agric Food Chem 61:10354-10359, 2013.
17. Nijveldt RJ, Van Nood E, Van Hoorn DE, Boelens PG, Van Norren K and Van Leeuwen PA: Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418-425, 2001.
18. Thilakarathna SH and Rupasinghe HP: Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 5:3367-3387, 2013.
19. Beking K and Vieira A: Flavonoid intake and disability-adjusted life years due to Alzheimer's and related dementias: a population-based study involving twenty-three developed countries. Public Health Nutr 13:1403-1409, 2010.
20. Letenneur L, Proust-Lima C, Le Gouge A, Dartigues JF and Barberger-Gateau P: Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 165:1364-1371, 2007.
21. Fu X, Zhang J, Guo L, Xu Y, Sun L, Wang S, Feng Y, Gou L, Zhang L and Liu Y: Protective role of luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats. Pharmacol Biochem Behav 126:122-130, 2014.
22. Liu Y, Fu X, Lan N, Li S, Zhang J, Wang S, Li C, Shang Y, Huang T and Zhang L: Luteolin protects against high fat diet-induced cognitive deficits in obesity mice. Behav Brain Res 267:178-188, 2014.
23. Rezai-Zadeh K, Douglas Shytle R, Bai Y, Tian J, Hou H, Mori T, Zeng J, Obregon D, Town T and Tan J: Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease beta-amyloid production. J Cell Mol Med 13:574-588, 2009.
24. Zhou F, Chen S, Xiong J, Li Y and Qu L: Luteolin reduces zinc-induced tau phosphorylation at Ser262/356 in an ROS-dependent manner in SH-SY5Y cells. Biol Trace Elem Res 149:273-279, 2012.
25. Sawmiller D, Li S, Shahaduzzaman M, Smith AJ, Obregon D, Giunta B, Borlongan CV, Sanberg PR and Tan J: Luteolin reduces Alzheimer's disease pathologies induced by traumatic brain injury. Int J Mol Sci 15:895-904, 2014.
26. Sharifzadeh M, Naghdi N, Khosrovani S, Ostad SN, Sharifzadeh K and Roghani A: Post-training intrahippocampal infusion of the COX-2 inhibitor celecoxib impaired spatial memory retention in rats. Eur J Pharmacol 511:159-166, 2005.
27. Tabrizian K, Najafi S, Belaran M, Hosseini-Sharifabad A, Azami K, Hosseini A, Soodi M, Kazemi A, Abbas A and Sharifzadeh M: Effects of selective iNOS inhibitor on spatial memory in recovered and non-recovered ketamine induced-anesthesia in wistar rats. Iran J Pharm Res 9:313-320, 2010.
28. Shimoi K, Masuda S, Furugori M, Esaki S and Kinae N: Radioprotective effect of antioxidative flavonoids in gamma-ray irradiated mice. Carcinogenesis 15:2669-2672, 1994.
29. Seelinger G, Merfort I and Schempp CM: Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med 74:1667-1677, 2008.
30. Yasukawa K, Takido M, Takeuchi M and Nakagawa S: Effect of chemical constituents from plants on 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Chem Pharm Bull (Tokyo) 37:1071-1073, 1989.
31. Majumdar D, Jung KH, Zhang H, Nannapaneni S, Wang X, Amin AR, Chen Z, Chen ZG and Shin DM: Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity. Cancer Prev Res (Phila) 7:65-73, 2014.
32. Ferriola PC, Cody V and Middleton E Jr: Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 38:1617-1624, 1989.
33. Nekohashi M, Ogawa M, Ogihara T, Nakazawa K, Kato H, Misaka T, Abe K and Kobayashi S: Luteolin and quercetin affect the cholesterol absorption mediated by epithelial cholesterol transporter niemann-pick c1-like 1 in caco-2 cells and rats. PLoS One 9:e97901, 2014.
34. Bast A, Kaiserová H, Den Hartog GJ, Haenen GR and Van Der Vijgh WJ: Protectors against doxorubicin-induced cardiotoxicity: Flavonoids. Cell Biol Toxicol 23:39-47, 2007.
35. Salkovic-Petrisic M and Hoyer S: Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm Suppl 72:217-233, 2007.
36. Grünblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P and Hoyer S: Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 101:757-770, 2007.
37. Maiese K and Chong ZZ: Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease. Restor Neurol Neurosci 22:87-104, 2004.
38. Behl C, Davis JB, Lesley R and Schubert D: Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77:817-827, 1994.
39. Varadarajan S, Yatin S, Kanski J, Jahanshahi F and Butterfield DA: Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress. Brain Res Bull 50:133-141, 1999.
40. Sharma M and Gupta YK: Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci 68:1021-1029, 2001.
41. Selkoe DJ: Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81:741-766, 2001.
42. Rasoolijazi H, Joghataie MT, Roghani M and Nobakht M: The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis. Iran Biomed J 11:237-243, 2007.
43. Gilgun-Sherki Y, Rosenbaum Z, Melamed E and Offen D: Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 54:271-284, 2002.
44. Subramaniam R, Koppal T, Green M, Yatin S, Jordan B, Drake J and Butterfield DA: The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide (25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease. Neurochem Res 23:1403-1410, 1998.
45. Yu D, Li M, Tian Y, Liu J and Shang J: Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury. Life Sci 122:15-25, 2015.
46. Pratheeshkumar P, Son YO, Divya SP, Roy RV, Hitron JA, Wang L, Kim D, Dai J, Asha P, Zhang Z, et al: Luteolin inhibits Cr (VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways. Toxicol Appl Pharmacol 281:230-241, 2014.
47. Xia F, Wang C, Jin Y, Liu Q, Meng Q, Liu K and Sun H: Luteolin protects HUVECs from TNF-α-induced oxidative stress and inflammation via its effects on the Nox4/ROS-NF-κb and MAPK pathways. J Atheroscler Thromb 21:768-783, 2014.